Evidence map›Paper›PMID 39766234›Full record

ArticleBiomolecules2024

Success of an Inpatient Rehabilitation Program in Subjects with Type 2 Diabetes Mellitus with or Without Metabolic Syndrome.

Bettina Thauerer, Anna Odrovicsné Tóth, Andreas Salzer, Bibiane Steinecker-Frohnwieser

Abstract read
In one paragraph

Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bettina ThauererLudwig Boltzmann Institute for Arthritis and Rehabilitation, 5760 Saalfelden, Austria.ORCID 0000-0001-8357-4082
Anna Odrovicsné TóthLudwig Boltzmann Institute for Arthritis and Rehabilitation, 5760 Saalfelden, Austria.ORCID 0009-0001-1662-4622
Andreas SalzerRehabilitation Center Saalfelden of the Pension Insurance Institution, 5760 Saalfelden, Austria.
Bibiane Steinecker-FrohnwieserLudwig Boltzmann Institute for Arthritis and Rehabilitation, 5760 Saalfelden, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionType 2 diabetes mellitus (T2DM) comprises heterogeneous disorders, which have an increase in blood glucose concentrations in common. Metabolic syndrome (MetS) describes the simultaneous occurrence of several clinical symptoms that increase the risk of cardiovascular disease and T2DM, although T2DM itself is also considered a risk factor for developing MetS.

objectiveThis study aimed to identify parameters related to rehabilitation success and relevant to MetS in T2DM patients.

methodsT2DM patients were divided into two subgroups based on the NHLBI/AHA and IDF guidelines for characterizing MetS. Serum samples were analyzed for T2DM-specific parameters, lipid metabolism, oxidative processes, AGE activity (AAct), and uric acid to HDL ratio (UHR) at admission and discharge after a 3-week inpatient rehabilitation stay. Logistic regression and before-after comparisons were performed showing the importance of multidisciplinary rehabilitation.

resultsAmong eighty-six patients, 59.3% had MetS. Significant differences between subgroups were found in fasting glucose (FBS), hemoglobin A1c (HbA1c), high-density lipoprotein cholesterol (HDL), triglycerides (TGLs), soluble receptor for AGE (sRAGE), UHR, and AAct. Rehabilitation-induced changes in disease-related parameters were influenced by the presence of MetS. The predictive capacity from all parameters together could be reduced within the three weeks.

conclusionRehabilitative measures have a major influence on MetS-relevant factors and can change the course of the disease in patients with T2DM. Identifying these factors can be of great importance for future diagnoses and treatments of T2DM and MetS.

Indexed as

Diabetes Mellitus, Type 2InpatientsMetabolic SyndromeAgedBlood GlucoseCholesterol, HDLFemaleGlycated HemoglobinHumansMaleMiddle AgedTriglyceridesUric AcidBlood GlucoseCholesterol, HDLGlycated HemoglobinTriglyceridesUric Acidadvanced glycation end products (AGEs)lipid metabolismmetabolic syndrome (MetS)oxidative stressprediction modelrehabilitation outcomesoluble receptor for AGE (sRAGE)type 2 diabetes mellitus (T2DM)

Identifiers

PMID39766234
PMCPMC11673746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.